この作品は、国立衛生研究所（DBCにHL068915）、（CAP）のスラッシャー研究基金からの新しい研究者賞、補助金、米国心臓協会（DBCへ12GRNT11910008）からの研究助成金によってサポートされていました（DBC）は、ボストン小児病院の心臓伝導基金、ライアンファミリー基金への寄付、そしてデビッド·プルマンによる子供の心臓財団からの研究助成金。

ここでは、子羊の皮からCOL1の分離のデモンストレーションを行います。書かれたように、このプロトコルはまた、正常ウサギおよびヒトの皮膚からCOL1を単離するために使用することができる。 1。皮膚のサンプルを準備します<ol><li>使用前に4℃にすべての試薬を平衡化させます。 </li><li>氷のように冷たいのdH 2 O中で真皮サンプル（25〜g）をすすぎ、脱毛クリームを持つウール、毛皮、または髪を削除します。 </li><li>結合組織および脂肪のサンプルクリーンをこすりするために単一のエッジかみそりの刃を使用してください。 </li><li>氷のように冷たいのdH 2 Oのサンプルをすすぐ</li><li>シングルエッジかみそりの刃で1センチメートル×1センチの部分に皮膚サンプルをスライス。 </li></ol> 2。非コラーゲン可溶化物質を除去<ol><li>サンプル50ミリリットルあたりのコニカルチューブの5グラムを秤量し、氷冷した0.5 M酢酸ナトリウム30ミリリットルを追加します。 </li><li>ベンチトップホモジナイザー中で50mlのチューブアダプタを使用して6m /秒の設定で1分間チューブを混合する。 </li><li> SUPを破棄7酢酸ナトリウムの洗浄サイクルの合計ernatant繰り返し。 </li><li>氷のように冷たいのdH 2 Oの中に試料をすすぎ、残留酢酸ナトリウムを除去するために、一度ミックス。 </li><li>過剰な液体を除去した後、新しい50mlコニカルチューブに転送するためにチューブの側面に対してサンプルを圧縮するヘラを使用しています。 </li></ol> 3。私コラーゲンの抽出を入力<ol><li>試料を圧縮し、各洗浄後に上清を捨てベンチトップホモジナイザーで6m /秒で1分間ミリリットル/ gの2倍のサンプルを洗浄0.075 Mクエン酸ナトリウム緩衝液。 </li><li>サンプルに0.075 Mクエン酸ナトリウム緩衝液の新鮮な2ミリリットル/ gのアリコートを追加します。 </li><li>各サイクルの間にバッファを削除せずに6連続した1分、攪拌の6メートル/秒のベンチトップホモジナイザーミックスサイクルを実行します。 </li><li>コレクションチューブに厚く、透明な上澄みを転送します。 </li><li>サンプルにミリリットル/ g、さらに1 0.075 Mクエン酸ナトリウム緩衝液を加え、1の最終ベンチトップホモジナイザー胸焼けを行うクル。 </li><li>コレクションチューブにこの最終上清を追加します。 </li><li>遠心機で4℃で10分間、3,200×gで回収チューブ</li><li>分子量100,000の最上部のコンパートメントに上清を移し、遠心フィルター装置を遮断。 </li><li> 4℃で30分間3200×gで遠心分離</li><li> 4℃のクリーンコニカルチューブおよび格納するために上部コンパートメントから精製されたCOL1を転送</li></ol>

<ol>
	<li>Nageotte, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Coagulation+fibrillaire+in+vitro+du+collag&#232;ne+dissous+dans+un+acide+dilu&#233;.">Coagulation fibrillaire in vitro du collag&#232;ne dissous dans un acide dilu&#233;.</a> CR hebd. s&#233;ances Acad. Sei. 184, 115 (1927).</li><li>Schmitt, F. O., Hall, C. E., Jakus, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Electron+microscope+investigation+of+the+structure+of+collagen.">Electron microscope investigation of the structure of collagen.</a> J. Cell Comp. Physiol. 20, 11-33 (1942).</li><li>Choi, Y. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiac+conduction+through+engineered+tissue.">Cardiac conduction through engineered tissue.</a> Am. J. Pathol. 169, 72-85 (2006).</li><li>Pacak, C. A., Cowan, D. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Fabrication+of+myogenic+engineered+tissue+constructs.">Fabrication of myogenic engineered tissue constructs.</a> J. Vis. Exp. (27), (2009).</li><li>Cliche, S., Amiot, J., Avezard, C., Gariepy, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Extraction+and+characterization+of+collagen+with+or+without+telopeptides+from+chicken+skin.">Extraction and characterization of collagen with or without telopeptides from chicken skin.</a> Poultry Sci. 82, 503-509 (2003).</li><li>Rajan, N., Habermehl, J., Cote, M. F., Doillon, C. J., Mantovani, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Preparation+of+ready-to-use,+storable+and+reconstituted+type+I+collagen+from+rat+tail+tendon+for+tissue+engineering+applications.">Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications.</a> Nat. Protoc. 1, 2753-2758 (2006).</li><li>Seifter, S., Gallop, P., Colowick, S., Kaplan, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Preparation+and+properties+of+soluble+collagens.">Preparation and properties of soluble collagens.</a> Methods in Enzymology. , (1963).</li><li>Pacak, C. A., Powers, J. M., Cowan, D. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ultrarapid+purification+of+collagen+type+I+for+tissue+engineering+applications.">Ultrarapid purification of collagen type I for tissue engineering applications.</a> Tissue Eng. Part C Methods. 17, 879-885 (2011).</li><li>Ohan, M. P., Dunn, M. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Glucose+stabilizes+collagen+sterilized+with+gamma+irradiation.">Glucose stabilizes collagen sterilized with gamma irradiation.</a> J. Biomed. Mater. Res. A. 67, 1188-1195 (2003).</li><li>Tyan, Y. C., Liao, J. D., Lin, S. P., Chen, C. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+study+of+the+sterilization+effect+of+gamma+ray+irradiation+of+immobilized+collagen+polypropylene+nonwoven+fabric+surfaces.">The study of the sterilization effect of gamma ray irradiation of immobilized collagen polypropylene nonwoven fabric surfaces.</a> J. Biomed. Mater. Res. A. 67, 1033-1043 (2003).</li><li>Ber, S., Torun Kose, G., Hasirci, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bone+tissue+engineering+on+patterned+collagen+films:+an+in+vitro+study.">Bone tissue engineering on patterned collagen films: an in vitro study.</a> Biomaterials. 26, 1977-1986 (2005).</li><li>Liu, Y., Sun, S., Singha, S., Cho, M. R., Gordon, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=3-D+femtosecond+laser+patterning+of+collagen+for+directed+cell+attachment.">3-D femtosecond laser patterning of collagen for directed cell attachment.</a> Biomaterials. 26, 4597-4605 (2005).</li><li>Thakar, R. G., Ho, F., Huang, N. F., Liepmann, D., Li, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Regulation+of+vascular+smooth+muscle+cells+by+micropatterning.">Regulation of vascular smooth muscle cells by micropatterning.</a> Biochem. Biophys. Res. Comm. 307, 883-890 (2003).</li><li>Leighton, J., Justh, G., Esper, M., Kronenthal, R. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Collagen-coated+cellulose+sponge:+three+dimensional+matrix+for+tissue+culture+of+Walker+tumor+256.">Collagen-coated cellulose sponge: three dimensional matrix for tissue culture of Walker tumor 256.</a> Science. 155, 1259-1261 (1967).</li></ol>

著者らは、開示することなく、競合する金融利害関係はありません。

この方法の重要な要素は、過剰な液体を除去し、皮膚のサンプルを繰り返し効率的な圧縮です。これは、試料を圧縮することによって、ステップ2.5においてできるだけ酢酸ナトリウムを除去することが重要である。我々は、チューブの側面に対して皮膚を圧縮するためにスパチュラを使用しているが、チーズクロスを使用することもできる、これがチューブからのサンプルの除去を必要とし?...

何十年もの間、研究者や商業ベンダーが使用することができる組織化されたCOL1原線維のマトリックスの再懸濁、その結果中​​和し、単純な酸抽出プロトコルのいくつかのバリエーションを使用して皮膚や腱などの組織源の品揃えから可溶化COL1を単離した生物医学的応用1-4多数のため。 col1の臨床応用の多くの例がありますが、このタンパク質の調製は5-7を実行するために数日から数週間を取って長々抽出を必要とするので、これらのいくつかは自家由来COL1を採用しています。その結果、研究調査官や医師は、一般的には、ラット、ウシ、またはブタ真皮などの非ヒト組織を用いたか、死体から摘出皮膚を使用したり、男性の割礼に従って製造されたCOL1の高価な、市販製剤を使用しています。再生アプリケーション、固体形成する能力に関して、これらの製品の多くの展示可変性マトリックスまたは細胞の付着および成長を支持することが可能な組織構築物。そのため、すぐにアクセス可能で、豊富な自家組織源からCOL1を抽出するために設計された新しい標準化された方法のための明確な必要性がある。 そのような方法は、COL1は、関心のある動物モデルから抽出したコラーゲンベースの足場上で組み立て設計組織の前臨床試験を使用することができる研究環境で、時間とコストの両方を節約することになる。同時に、診療​​所で急速に分離された、自家由来COL1を使用するオプションを有する他の方法で同種または異種の準備を受け取ることになる患者のための全体的な安全性を増加させるであろう。自家調製を受けている患者の場合、この方法は非常に合理化された生検収集およびコラーゲンアプリケーションとの間の間隔を減少させるであろう。これらの理由から、我々は、高速AGを使用して、長い確立COL1の単離および精製方法を改善しようとしたitationおよびサイズ​​排除遠心分離。この方法は、多くの研究室で見られる標準バッファーと装置を使用して実行するのは簡単です。高速攪拌を用いることにより、我々のプロトコルは3未満〜8時間、約10日から可溶性、皮膚COL1を単離するために必要な時間を短縮する。重要なことに、この方法は、容易な手順の単一のセット中の患者に使用するための自​​家由来するCOL1を調製するために臨床設定で行うことができる。

<table border="0" cellpadding="0" cellspacing="0" width="544">
	<colgroup>
		<col />
		<col />
		<col />
		<col />
	</colgroup>
	<tbody>
		<tr height="43">
			<td height="43" style="height:43px;width:123px;">FastPrep-24 System</td>
			<td style="width:136px;">MP Biomedicals</td>
			<td style="width:147px;">116004500</td>
			<td style="width:139px;">-</td>
		</tr>
		<tr height="190">
			<td height="190" style="height:190px;width:123px;">Centrifuge</td>
			<td style="width:136px;">Beckman</td>
			<td style="width:147px;">J6-MI</td>
			<td style="width:139px;">Swing bucket rotor to accommodate 50 mL conical tubes at 3200 g.</td>
		</tr>
	</tbody>
</table>

an improved method for the preparation of type i collagen from skin

水溶性タイプ1コラーゲン（COL1）は、細胞培養用の接着基質として、再生アプリケーションのための携帯足場として広く使用されています。臨床的に、このタンパク質は、広く美容外科、皮膚注射、骨移植および再建手術のために使用される。これらの手順のcol1のソースは、炎症や拒絶反応の可能性だけでなく、生体異物疾病伝播を増加させる、一般的にヒト以外である。そこで、効率的かつ迅速に自家由来組織の限られた量からCOL1を精製する方法は、これらの問題の多くを回避するであろうが、標準の単離プロトコルが長いであり、多くの場合、コラーゲン様組織を大量に必要とする。ここでは、約10日から約3時間後に、このタンパク質を単離および精製するために必要な時間を短縮し、効率的なCOL1抽出方法を示す。我々は、多くの外科的処置の際に、その利用可能性の我々の組織源として真皮を選びました。 T彼の方法は、真皮、少量から高純度、溶解性のCOL1を得るための強力な撹拌及び遠心濾過と組み合わせた伝統的な抽出バッファを使用しています。簡潔には、皮膚生検、脂肪、結合組織、毛髪を除去した後、氷冷のdH 2 Oで十分に洗浄する。皮膚サンプルを0.5 M酢酸ナトリウムおよび高速ベンチトップホモジナイザーを用いて非コラーゲン性タンパク質及び多糖類から取り除かれる。残留固形物由来のコラーゲンは、その後、ホモジナイザーを用いて0.075 Mクエン酸ナトリウム緩衝液で抽出する。これらの抽出物は、100,000 MWカットオフ市販品または従来の手順を用いて得られたものと同等以上の品質のCOL1製剤を得る遠心フィルタを使用して精製される。我々は、この方法では、研究と臨床応用の多数のための自家由来COL1の利用を容易にするであろうと予想している。

このCOL1単離プロトコールは、完了するのに約2時間と15分が必要です。図1は、この手順の主なステップを概説する概略図を示す。試料を調製し、高速攪拌回転の7サイクルを実行し、酢酸ナトリウムでリンスすると、約35分（図1A-C）をとる。 1の攪拌を実施するとDH 2 Oですすぎサイクルは約5分（図1Dおよび1E）を取ります。クエン酸ナトリウムを加?...

Watch this Scientific Journal Video about An Improved Method for the Preparation of Type I Collagen From Skin at JoVE.com

An Improved Method for the Preparation of Type I Collagen From Skin

水溶性タイプ1コラーゲン（COL1）を単離するための伝統的な手続きが原因に長いバッファインキュベーションおよびフィブリルの面倒な再懸濁の開始から終了まで約10日を要する。ここでは、3時間未満の小さな皮膚生検からCOL1を精製するための手段を記載する。

皮膚からのI型コラーゲンの調製のための改良された方法

Soluble type 1 collagen (COL1) is used extensively as an adhesive substrate for cell cultures and as a cellular scaffold for regenerative applications. ...

an-improved-method-for-the-preparation-of-type-i-collagen-from-skin

Research

JoVE Journal

Bioengineering

22.7K ビュー.  Boston Children's Hospital. 水溶性タイプ1コラーゲン（COL1）を単離するための伝統的な手続きが原因に長いバッファインキュベーションおよびフィブリルの面倒な再懸濁の開始から終了まで約10日を要する。ここでは、3時間未満の小さな皮膚生検からCOL1を精製するための手段を記載する。 

ビデオ: An Improved Method for the Preparation of Type I Collagen From Skin

Organotypic Collagen I Assay: A Malleable Platform to Assess Cell Behaviour in a 3-Dimensional Context

Cell migration is fundamental to many aspects of biology, including development, wound healing, the cellular responses of the immune system, and metastasis of tumor cells. Migration has been studied on glass coverslips in order to make cellular dynamics amenable to investigation by light microscopy. However, it has become clear that many aspects of cell migration depend on features of the local environment including its elasticity, protein composition, and pore size, which are not faithfully represented by rigid two dimensional substrates such as glass and plastic 1. Furthermore, interaction with other cell types, including stromal fibroblasts 2 and immune cells 3, has been shown to play a critical role in promoting the invasion of cancer cells. Investigation at the molecular level has increasingly shown that molecular dynamics, including response to drug treatment, of identical cells are significantly different when compared in vitro and in vivo 4. 
Ideally, it would be best to study cell migration in its naturally occurring context in living organisms, however this is not always possible. Intermediate tissue culture systems, such as cell derived matrix, matrigel, organotypic culture (described here) tissue explants, organoids, and xenografts, are therefore important experimental intermediates. These systems approximate certain aspects of an in vivo environment but are more amenable to experimental manipulation such as use of stably transfected cell lines, drug treatment regimes, long term and high-resolution imaging. Such intermediate systems are especially useful as proving grounds to validate probes and establish parameters required to image the dynamic response of cells and fluorescent reporters prior to undertaking imaging in vivo 5. As such, they can serve an important role in reducing the need for experiments on living animals.

A method is described for the preparation of a 3-dimensional matrix consisting of collagen type I and primary human fibroblasts. This organotypic gel serves as a useful substrate to assess invasive cell migration because it mimics basic features of tissue stroma and is amenable to many forms of microscopy.

器官型コラーゲンIアッセイ：3次元コンテキストでのセルの挙動を評価するための可鍛性プラットフォーム

Cell migration is fundamental to many aspects of biology, including development, wound healing, the cellular responses of the immune system, and ...

生物工学

Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier

The blood-brain barrier (BBB) comprises impermeable but adaptable brain capillaries which tightly control the brain environment. Failure of the BBB has been implied in the etiology of many brain pathologies, creating a need for development of human in vitro BBB models to assist in clinically-relevant research. Among the numerous BBB models thus far described, a static (without flow), contact BBB model, where astrocytes and brain endothelial cells (BECs) are cocultured on the opposite sides of a porous membrane, emerged as a simplified yet authentic system to simulate the BBB with high throughput screening capacity. Nevertheless the generation of such model presents few technical challenges. Here, we describe a protocol for preparation of a contact human BBB model utilizing a novel combination of primary human BECs and immortalized human astrocytes. Specifically, we detail an innovative method for cell-seeding on inverted inserts as well as specify insert staining techniques and exemplify how we use our model for BBB-related research.

Establishment of human models of the blood-brain barrier (BBB) can benefit research into brain conditions associated with BBB failure. We describe here an improved technique for preparation of a contact BBB model, which permits coculturing of human astrocytes and brain endothelial cells on the opposite sides of a porous membrane.

人間の細胞に基づく、血液脳関門の接触モデルの作製のための改善された方法

The blood-brain barrier (BBB) comprises impermeable but adaptable brain capillaries which tightly control the brain environment. Failure of the BBB has ...

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage

Recent advances in material science have led to a substantial increase in the topographical complexity of implant surfaces, both on a micro- and a nano-scale. As such, traditional methods of describing implant surfaces -&#160;namely numerical determinants of surface roughness -&#160;are inadequate for predicting in vivo performance. Biomechanical testing provides an accurate and comparative platform to analyze the performance of biomaterial surfaces. An improved mechanical testing method to test the anchorage of bone to candidate implant surfaces is presented. The method is applicable to both early and later stages of healing and can be employed for any range of chemically or mechanically modified surfaces -&#160;but not smooth surfaces. Custom rectangular implants are placed bilaterally in the distal femora of male Wistar rats and collected with the surrounding bone. Test specimens are prepared and potted using a novel breakaway mold and the disruption test is conducted using a mechanical testing machine. This method allows for alignment of the disruption force exactly perpendicular, or parallel, to the plane of the implant surface, and provides an accurate and reproducible means for isolating an exact peri-implant region for testing.

An improved method to mechanically test bone anchorage to candidate implant surfaces is presented. This method allows for alignment of the disruption force exactly perpendicular, or parallel, to the plane of the implant surface, and provides an accurate means to direct the disruption forces to an exact peri-implant region.

骨 - インプラントアンカレッジ評価するために改良された機械的試験方法

Recent advances in material science have led to a substantial increase in the topographical complexity of implant surfaces, both on a micro- and a ...

Engineering 3D Cellularized Collagen Gels for Vascular Tissue Regeneration

Synthetic materials are known to initiate clinical complications such as inflammation, stenosis, and infections when implanted as vascular substitutes. Collagen has been extensively used for a wide range of biomedical applications and is considered a valid alternative to synthetic materials due to its inherent biocompatibility (i.e., low antigenicity, inflammation, and cytotoxic responses). However, the limited mechanical properties and the related low hand-ability of collagen gels have hampered their use as scaffold materials for vascular tissue engineering. Therefore, the rationale behind this work was first to engineer cellularized collagen gels into a tubular-shaped geometry and second to enhance smooth muscle cells driven reorganization of collagen matrix to obtain tissues stiff enough to be handled.
The strategy described here is based on the direct assembling of collagen and smooth muscle cells (construct) in a 3D cylindrical geometry with the use of a molding technique. This process requires a maturation period, during which the constructs are cultured in a bioreactor under static conditions (without applied external dynamic mechanical constraints) for 1 or 2 weeks. The &#8220;static bioreactor&#8221; provides a monitored and controlled sterile environment (pH, temperature, gas exchange, nutrient supply and waste removal) to the constructs. During culture period, thickness measurements were performed to evaluate the cells-driven remodeling of the collagen matrix, and glucose consumption and lactate production rates were measured to monitor the cells metabolic activity. Finally, mechanical and viscoelastic properties were assessed for the resulting tubular constructs. To this end, specific protocols and a focused know-how (manipulation, gripping, working in hydrated environment, and so on) were developed to characterize the engineered tissues.

In this work, we present a technique for the rapid fabrication of living vascular tissues by direct culturing of collagen, smooth muscle cells and endothelial cells. In addition, a new protocol for the mechanical characterization of engineered vascular tissues is described.

エンジニアリング3D細胞化血管組織再生のためのコラーゲンゲル

Synthetic materials are known to initiate clinical complications such as inflammation, stenosis, and infections when implanted as vascular substitutes. ...

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair

Conventional techniques for cell expansion and transplantation of autologous cells for tissue engineering purposes can take place in specially equipped human cell culture facilities. These methods include isolation of cells in single cell suspension and several laborious and time-consuming events before transplantation back to the patient. Previous studies suggest that the body itself could be used as a bioreactor for cell expansion and regeneration of tissue in order to minimize ex vivo manipulations of tissues and cells before transplanting to the patient. The aim of this study was to demonstrate a method for tissue harvesting, isolation of continuous epithelium, mincing of the epithelium into small pieces and incorporating them into a three-layered biomaterial. The three-layered biomaterial then served as a delivery vehicle, to allow surgical handling, exchange of nutrition across the transplant, and a controlled degradation. The biomaterial consisted of two outer layers of collagen and a core of a mechanically stable and slowly degradable polymer. The minced epithelium was incorporated into one of the collagen layers before transplantation. By mincing the epithelial tissue into small pieces, the pieces could be spread and thereby the propagation of cells was stimulated. After the initial take of the transplants, cell expansion and reorganization would take place and extracellular matrix mature to allow ingrowth of capillaries and nerves and further maturation of the extracellular matrix. The technique minimizes ex vivo manipulations and allow cell harvesting, preparation of autograft, and transplantation to the patient as a simple one-stage intervention. In the future, tissue expansion could be initiated around a 3D mold inside the body itself, according to the specific needs of the patient. Additionally, the technique could be performed in an ordinary surgical setting without the need for sophisticated cell culturing facilities.

Tissue engineering often includes in vitro expansion in order to create autografts for tissue regeneration. In this study a method for tissue expansion, regeneration, and reconstruction in vivo was developed in order to minimize the processing of cells and biological materials outside the body.

圧縮されたコラーゲンで細分化した組織：シングル段再建修復のための細胞含有Biotransplant

Conventional techniques for cell expansion and transplantation of autologous cells for tissue engineering purposes can take place in specially equipped ...

Preparation of 3D Collagen Gels and Microchannels for the Study of 3D Interactions In Vivo

Historically, most cellular processes have been studied in only 2 dimensions. While these studies have been informative about general cell signaling mechanisms, they neglect important cellular cues received from the structural and mechanical properties of the local microenvironment and extracellular matrix (ECM). To understand how cells interact within a physiological ECM, it is important to study them in the context of 3 dimensional assays. Cell migration, cell differentiation, and cell proliferation are only a few processes that have been shown to be impacted by local changes in the mechanical properties of a 3-dimensional ECM. Collagen I, a core fibrillar component of the ECM, is more than a simple structural element of a tissue. Under normal conditions, mechanical cues from the collagen network direct morphogenesis and maintain cellular structures. In diseased microenvironments, such as the tumor microenvironment, the collagen network is often dramatically remodeled, demonstrating altered composition, enhanced deposition and altered fiber organization. In breast cancer, the degree of fiber alignment is important, as an increase in aligned fibers perpendicular to the tumor boundary has been correlated to poorer patient prognosis1. Aligned collagen matrices result in increased dissemination of tumor cells via persistent migration2,3. The following is a simple protocol for embedding cells within a 3-dimensional, fibrillar collagen hydrogel. This protocol is readily adaptable to many platforms, and can reproducibly generate both aligned and random collagen matrices for investigation of cell migration, cell division, and other cellular processes in a tunable, 3-dimensional, physiological microenvironment.

Preparation of 3D Collagen Gels and Microchannels for the Study of 3D Interactions In Vivo

Collagen is a core component of the ECM, and provides essential cues for several cellular processes ranging from migration to differentiation and proliferation. Provided here is a protocol for embedding cells within 3D collagen hydrogels, and a more advanced technique for generating randomized or aligned collagen matrices using PDMS microchannels.

3D相互作用の研究のための3Dコラーゲンゲルおよびマイクロチャネルの作製<em&gt;インビボ</em

Historically, most cellular processes have been studied in only 2 dimensions.  While these studies have been informative about general cell signaling ...

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates

Type I collagen, useful as a substrate for cell culture, exists in two forms: the two-dimensional, non-fibrous form and three-dimensional, fibril form. Both forms can be prepared with the same type I collagen. In general, the non-fibrous form promotes cell adhesion and proliferation. The fibril form (gels) provides more physiological conditions in many types of cells; therefore, gel culture is useful for examining physiological behaviors of cells, such as drug efficacy.
Researchers can select the appropriate form according to the purpose of its use. For example, in the case of keratinocytes, on-gel culture has been used as a wound healing model. FEPE1L-8, a keratinocyte cell line cultured on the non-fibrous form of type I collagen, promote cell adhesion. Notably, keratinocyte proliferation is slower on the fibril form than the non-fibrous form. Protocols for the preparation of type I collagen for cell culture are simple and have wide applications depending on the experimental needs.

Here, we present a protocol for the preparation of two different forms of culture substrates utilizing type I collagen. Depending on how collagen is handled, collagen molecules either maintain two-dimensional, non-fibrous form or reassemble into three-dimensional, fibril form. Cell proliferation on type I collagen is drastically affected by fibril formation.

ケラチン生成細胞増殖の 2 次元と 3 次元の評価タイプ I コラーゲン基板

Type I collagen, useful as a substrate for cell culture, exists in two forms: the two-dimensional, non-fibrous form and three-dimensional, fibril form. ...

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

The kynurenine pathway and the tryptophan catabolites called kynurenines have received increased attention for their involvement in immune regulation and cancer biology. An in vitro cell culture assay is often used to learn about the contribution of different tryptophan catabolites in a disease mechanism and for testing therapeutic strategies. Cell culture medium that is rich in secreted metabolites and signaling molecules reflects the status of tryptophan metabolism and other cellular events. New protocols for the reliable quantification of multiple kynurenines in the complex cell culture medium are desired to allow for a reliable and quick analysis of multiple samples. This can be accomplished with liquid chromatography coupled with mass spectrometry. This powerful technique is employed in many clinical and research laboratories for the quantification of metabolites and can be used for measuring kynurenines.
Presented here is the use of liquid chromatography coupled with single quadrupole mass spectrometry (LC-SQ) for the simultaneous determination of four kynurenines, i.e., kynurenine, 3-hydroxykynurenine, 3-hydroxyanthranilic, and xanthurenic acid in the medium collected from in vitro cultured cancer cells. SQ detector is simple to use and less expensive compared to other mass spectrometers. In the SQ-MS analysis, multiple ions from the sample are generated and separated according to their specific mass-to-charge ratio (m/z), followed by the detection using a Single Ion Monitoring (SIM) mode.
This paper draws the attention on the advantages of the reported method and indicates some weak points. It is focused on critical elements of LC-SQ analysis including sample preparation along with chromatography and mass spectrometry analysis. The quality control, method calibration conditions and matrix effect issues are also discussed. We described a simple application of 3-nitrotyrosine as one analog standard for all target analytes. As confirmed by experiments with human ovary and breast cancer cells, the proposed LC-SQ method&#160;generates reliable results and can be further applied to other in vitro cellular models.

Described here is a protocol for the determination of four different tryptophan metabolites generated in the kynurenine pathway (kynurenine, 3-hydroxykynurenine, xanthurenic acid, 3-hydroxyanthranilic acid) in the medium collected from cancer cell cultures analyzed by liquid chromatography coupled with a single quadrupole mass spectrometry.

癌細胞培養から採取した培地における液体クロマトグラフィー-質量分析法による選択キヌレニンの同時定量化

The kynurenine pathway and the tryptophan catabolites called kynurenines have received increased attention for their involvement in immune regulation and ...

組織損傷を軽減するための新しい低侵襲スローインジェクション法

A Novel Cell Injection Method with Minimum Invasion

Directly injecting cells into tissues is a necessary process in cell administration and/or replacement therapy. The cell injection requires a sufficient amount of suspension solution to allow the cells to enter the tissue. The volume of the suspension solution affects the tissue, and this can cause major invasive injury as a result of the cell injection. This paper reports on a novel cell injection method, called slow injection, that aims to avoid this injury. However, pushing out the cells from the needle tip requires a sufficiently high injection speed according to Newton's law of shear force. To solve the above contradiction, a non-Newtonian fluid, such as gelatin solution, was used as the cell suspension solution in this work. Gelatins solution have temperature sensitivity, as their form changes from gel to sol at approximately 20 &#176;C. Therefore, to maintain the cell suspension solution in the gel form, the syringe was kept cooled in this protocol; however, once the solution was injected into the body, the body temperature converted it to a sol. The interstitial tissue fluid flow can absorb excess solution. In this work, the slow injection technique allowed cardiomyocyte balls to enter the host myocardium and engraft without surrounding fibrosis. This study employed a slow injection method to inject purified and ball-formed neonatal rat cardiomyocytes into a remote area of myocardial infarction in the adult rat heart. At 2 months following the injection, the hearts of the transplanted groups showed significantly improved contractile function. Furthermore, histological analyses of the slow-injected hearts revealed seamless connections between the host and graft cardiomyocytes via intercalated disks containing gap junction connections. This method could contribute to next-generation cell therapies, particularly in cardiac regenerative medicine.

著者スポットライト:最小限の侵襲で新しい細胞注入法  

This method eliminates any major invasion during cell injections caused by the cell suspension solution.

浸潤の少ない新規細胞注入法

Directly injecting cells into tissues is a necessary process in cell administration and/or replacement therapy. The cell injection requires a sufficient ...